scholarly article | Q13442814 |
P2093 | author name string | Yang Y | |
Shimizu M | |||
Ohta K | |||
Koizumi S | |||
Kasahara Y | |||
Yachie A | |||
Nakai A | |||
P433 | issue | 1 | |
P304 | page(s) | 35-40 | |
P577 | publication date | 2005-07-01 | |
P1433 | published in | Clinical Nephrology | Q15763520 |
P1476 | title | Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin II receptor blocker (ARB) in pediatric patients with IgA nephropathy | |
P478 | volume | 64 |
Q80112924 | Add-on therapy with angiotensin II receptor 1 blocker in children with chronic kidney disease already treated with angiotensin-converting enzyme inhibitors |
Q37152477 | Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study |
Q35528122 | Changes in urinary angiotensinogen posttreatment in pediatric IgA nephropathy patients |
Q87393387 | Chapter 10: Immunoglobulin A nephropathy |
Q35819489 | Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial |
Q34891823 | Efficacy and safety of Shenyankangfu tablets for primary glomerulonephritis: study protocol for a randomized controlled trial |
Q33516579 | Efficacy and safety of angiotensin II receptor type 1 antagonists in children and adolescents |
Q84978295 | Evidence-based practice guideline for the treatment of CKD |
Q36739672 | Glomerular angiotensinogen protein is enhanced in pediatric IgA nephropathy |
Q36407313 | Hypertension in children with chronic kidney disease: pathophysiology and management |
Q57040510 | Lisinopril versus lisinopril and losartan for mild childhood IgA nephropathy: a randomized controlled trial (JSKDC01 study) |
Q34169794 | Risk factors for progression of chronic kidney disease |
Q35614311 | Therapeutic approach to FSGS in children |
Search more.